Blocking agents of EDRF effect or formation for the treatment of shock
US5081148A · kind A · utility
30Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 1990 |
| Grant date | Jan 14, 1992 |
| Priority date | — |
| Expiry date | Dec 19, 2010 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a therapeutical composition of matter for the treatment by perfusion of shock states comprising as an essential ingredient therein, an effective amount either, of a compound of the formula: ##STR1## wherein R.sub.1 and R.sub.4 stant for H or CH.sub.3 or C.sub.2 H.sub.5, PA1 R.sub.2 stands for H or NO.sub.2 and PA1 R.sub.3 stands for NHR.sub.4 or CH.sub.3 or C.sub.2 H.sub.5 alone or of a mixture of said compound with a cyclooxygenase blocker.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.